Kieger Healthcare Chart of the Month – Kieger
icon-menu-open Created with Sketch.
icon-menu-close Created with Sketch.
Kieger
icon-arrow Created with Sketch. icon-arrow Created with Sketch.
News
icon-arrow Created with Sketch. icon-arrow Created with Sketch.
Kieger Healthcare Chart of the Month

Kieger Healthcare Chart of the Month

Did you know that R&D expenses of the 15 biggest pharma companies have increased by almost 50% since 2016 to USD 133 bn in 2021?

And expenses will continue to increase. Roche alone for example will spend close to CHF 15 bn on R&D in 2022, 1 bn more than in 2021.

However, R&D success rates, as our chart shows, have not increased over the last decade, to the contrary, rates are back to below 10% also due to the pandemic.

R&D success rate is defined as the probability that a drug entering clinical trials will make it to the market.So in other words, less than 1 out of 10 products tested in patients makes it to market.

So what?, you might ask. Simply said, it remains really hard to develop new drugs, despite all the scientific and technological advances. The thing is… that science and technology progress is levelled off by increased complexity, higher safety standards and more competition

As investors it is key, that find companies which do R&D more efficient than others. Let us know, if you want to find out what we think who the winning companies are.

Related News

Healthcare
2. December 2022

Healthcare - Today's challenges, tomorrow's opportunities

40.97% - that's how much the HC market has returned since November 2019 until end of November 2022. It certainly has not been a straight line. Join our Kieger Healthcare specialists Urban Fritsche and Raphael Oesch as they look back at the last three healthcare investment years and discuss two current challenges and corresponding opportunities.

Healthcare
1. December 2022

Kieger Healthcare Monthly Commentary

Day after day currently feels like a roller coaster ride, going up because of better than hoped for CPI numbers, down because of looming recession fears, and back up because of a less hawkish FED speech. Are we there yet? What do you think?

Healthcare
25. November 2022

Kieger Healthcare Chart of the Month

It was a relief to see that children and adolescents suffered less from severe physical effects of COVID-19. However, they seem to be paying a heavy price when it comes to mental health.

Contact

icon-menu-close Created with Sketch.

Get in contact with us by using the form below or via telephone. We look forward to hearing from you.

Something is wrong
Something is wrong
Something is wrong
Something is wrong
Something is wrong
Something is wrong
Something is wrong
Something went wrong. Try again later.

Thank you!

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec, pellentesque eu, pretium quis, sem.

Kieger jobs

icon-menu-close Created with Sketch.

There are no job vacancies at the moment.